Skip to content

The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents

The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02440724
Acronym
SEMS
Enrollment
33
Registered
2015-05-12
Start date
2014-08-31
Completion date
2015-12-31
Last updated
2015-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Gastric Outlet Obstruction

Keywords

winged stents, Self-expandable Metal Stents(SEMS), partial covered, uncovered, endoscopic insertion

Brief summary

The purpose of this study is to evaluate usefulness of new designed winged stent(SEMS).

Interventions

DEVICEWinged stent (partially covered)

A winged stent is a newly designed self-expandable metal stents(SEMS). Partially covered, or uncovered winged stent will be placed via the endoscopic intervention for malignant gastric outlet obstruction.

DEVICEWinged stent (uncovered)

A winged stent is a newly designed self-expandable metal stents(SEMS). Partially covered, or uncovered winged stent will be placed via the endoscopic intervention for malignant gastric outlet obstruction.

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Gastric outlet obstruction symptom 2. Diagnosis of gastric outlet obstruction by radiologist or endoscopist 3. Gastric outlet obstruction by malignant disease 4. Aged over 19 5. Informed consent

Exclusion criteria

1. Gastric outlet obstruction by benign disease or infectious disease 2. Could not endoscopic intervention by poor general condition 3. Refusal of patient

Design outcomes

Primary

MeasureTime frameDescription
Complication rate(stent migration and tumor ingrowth) of new designed winged stentup to 16 weeks from stent insertionIt will be assessed by a composite measure consisting of physical exam, ECOG PS, GOOSS and gastrointestinal imaging.

Secondary

MeasureTime frameDescription
Evaluate the technical success rate of SEMS insertionup to 16 weeks from stent insertionIt will be assessed by a composite measure consisting of physical exam, ECOG PS, GOOSS and gastrointestinal imaging.
Evaluate the clinical success rate of SEMS insertionup to 16 weeks from stent insertionIt will be assessed by a composite measure consisting of physical exam, ECOG PS, GOOSS and gastrointestinal imaging.
Difference of insertion time between previous stent insertion and new designed stent1 years

Countries

South Korea

Contacts

Primary Contactmyungeun lee, BA
lme23@amc.seoul.kr+82-2-3010-7190
Backup ContactSojung Park, BA
sojung@amc.seoul.kr+82-2-3010-7190

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026